[
  {
    "ts": null,
    "headline": "What's next for GLP-1 weight-loss drugs in 2025?",
    "summary": "GLP-1 weight-loss drugs have dominated healthcare headlines in 2024, marked by expanded employer coverage, dynamic pricing changes, and pharmaceutical giants like Novo Nordisk (NVO) and Eli Lilly (LLY) exploring broader applications beyond weight management, including heart disease and sleep apnea treatments. Yahoo Finance Health Reporter Anjalee Khemlani dives into the details, analyzing the outlook for GLP-1 drugs as markets head into 2025. Also, catch Anjalee Khemlani highlight the three biggest catalysts for the healthcare industry expected in the new year. To watch more expert insights and analysis on the latest market action, check out more Market Domination here. This post was written by Angel Smith",
    "url": "https://finnhub.io/api/news?id=1f029c1f3a96f8489dbc131709c904839c81db9b41de6f89c972de54abae3e79",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1735069500,
      "headline": "What's next for GLP-1 weight-loss drugs in 2025?",
      "id": 132136182,
      "image": "",
      "related": "AMGN",
      "source": "Yahoo",
      "summary": "GLP-1 weight-loss drugs have dominated healthcare headlines in 2024, marked by expanded employer coverage, dynamic pricing changes, and pharmaceutical giants like Novo Nordisk (NVO) and Eli Lilly (LLY) exploring broader applications beyond weight management, including heart disease and sleep apnea treatments. Yahoo Finance Health Reporter Anjalee Khemlani dives into the details, analyzing the outlook for GLP-1 drugs as markets head into 2025. Also, catch Anjalee Khemlani highlight the three biggest catalysts for the healthcare industry expected in the new year. To watch more expert insights and analysis on the latest market action, check out more Market Domination here. This post was written by Angel Smith",
      "url": "https://finnhub.io/api/news?id=1f029c1f3a96f8489dbc131709c904839c81db9b41de6f89c972de54abae3e79"
    }
  },
  {
    "ts": null,
    "headline": "3 biggest catalysts expected for healthcare in 2025",
    "summary": "After an eventful year in the pharmaceutical and biotech industries, what lies ahead for the health landscape in 2025? Yahoo Finance senior health reporter Anjalee Khemlani outlines the three biggest catalysts for change and innovation for healthcare in the new year, including GLP-1 weight-loss drugs and proposed regulations on pharmacy benefit managers (PBMs) from the second Trump administration. To watch more expert insights and analysis on the latest market action, check out more Catalysts here. This post was written by Luke Carberry Mogan.",
    "url": "https://finnhub.io/api/news?id=d257b317d5d05997105840bc14ccb6a93eae24c968c53d9f1a66458a6df399af",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1735060800,
      "headline": "3 biggest catalysts expected for healthcare in 2025",
      "id": 132133934,
      "image": "https://s.yimg.com/ny/api/res/1.2/beEG94ULzRzpQ6PW9JqZAQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02NzY-/https://s.yimg.com/os/creatr-uploaded-images/2024-12/664ed980-c215-11ef-af3f-16c0199a30a2",
      "related": "AMGN",
      "source": "Yahoo",
      "summary": "After an eventful year in the pharmaceutical and biotech industries, what lies ahead for the health landscape in 2025? Yahoo Finance senior health reporter Anjalee Khemlani outlines the three biggest catalysts for change and innovation for healthcare in the new year, including GLP-1 weight-loss drugs and proposed regulations on pharmacy benefit managers (PBMs) from the second Trump administration. To watch more expert insights and analysis on the latest market action, check out more Catalysts here. This post was written by Luke Carberry Mogan.",
      "url": "https://finnhub.io/api/news?id=d257b317d5d05997105840bc14ccb6a93eae24c968c53d9f1a66458a6df399af"
    }
  },
  {
    "ts": null,
    "headline": "Amgen Inc. stock rises Tuesday, still underperforms market",
    "summary": "Amgen Inc. stock rises Tuesday, still underperforms market",
    "url": "https://finnhub.io/api/news?id=6a26a7cca558d43bc71c37c4f164d996c577b5735580da9b7dd9668a3d5beece",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1735058340,
      "headline": "Amgen Inc. stock rises Tuesday, still underperforms market",
      "id": 132147761,
      "image": "",
      "related": "AMGN",
      "source": "MarketWatch",
      "summary": "Amgen Inc. stock rises Tuesday, still underperforms market",
      "url": "https://finnhub.io/api/news?id=6a26a7cca558d43bc71c37c4f164d996c577b5735580da9b7dd9668a3d5beece"
    }
  }
]